Kamrine Poels
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 07, 2024
An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpoints.Nathan Braniff, Tanvi Joshi, Tyler Cassidy
|Sep 23, 2022
Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin
|Jan 25, 2022
Roadmap on plasticity and epigenetics in cancer.Jasmine Foo, David Basanta, Russell C Rockne
|Jun 18, 2021
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin
|Mar 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.Jacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo
Pageof 1
Frequent Collaborators
2 joint publications
Yosef Tobi
2 joint publications
Franziska Michor
1 joint publications
Robert Homer
1 joint publications
David Basanta
1 joint publications
Russell C Rockne
1 joint publications
Curran Shah
1 joint publications
Shannon M Mumenthaler
1 joint publications
Kelly Mitchell
1 joint publications
David Frankhouser
1 joint publications
Ya-Huei Kuo
